Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Change in Accured Expenses: 2022-2023

Historic Change in Accured Expenses for Therapeutics (LENZ) over the last 2 years, with Dec 2023 value amounting to $1.6 million.

  • Therapeutics' Change in Accured Expenses rose 256.73% to $1.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $7.8 million, marking a year-over-year increase of 601.17%. This contributed to the annual value of -$7.5 million for FY2024, which is 195.85% down from last year.
  • As of Q4 2023, Therapeutics' Change in Accured Expenses stood at $1.6 million, which was down 51.56% from $3.3 million recorded in Q3 2023.
  • Therapeutics' Change in Accured Expenses' 5-year high stood at $3.3 million during Q3 2023, with a 5-year trough of -$1.7 million in Q1 2022.
  • For the 2-year period, Therapeutics' Change in Accured Expenses averaged around $1.1 million, with its median value being $1.2 million (2022).
  • Data for Therapeutics' Change in Accured Expenses shows a peak YoY surged of 256.73% (in 2023) over the last 5 years.
  • Therapeutics' Change in Accured Expenses (Quarterly) stood at $453,000 in 2022, then soared by 256.73% to $1.6 million in 2023.
  • Its last three reported values are $1.6 million in Q4 2023, $3.3 million for Q3 2023, and $3.0 million during Q2 2023.